Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;15(3):331-337.
doi: 10.1016/j.jiph.2022.02.001. Epub 2022 Feb 3.

Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study

Mohammad Albanghali  1 , Saleh Alghamdi  2 , Mohammed Alzahrani  3 , Bassant Barakat  2 , Abdul Haseeb  4 , Jonaid Ahmad Malik  5 , Sakeel Ahmed  6 , Sirajudheen Anwar  7
Affiliations

Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study

Mohammad Albanghali et al. J Infect Public Health. 2022 Mar.

Abstract

Objective: Since the severity of symptoms affects the treatment option for Coronavirus Disease 2019 (COVID-19) patients, the treatment pattern for mild to moderate non-ICU cases must be evaluated, particularly in the current scenario of mutation and variant strain for effective decision making.

Methods: The objective of retrospective analysis was to assess clinical and treatment outcomes in mild to moderate symptoms in non-ICU patients with COVID-19 who were admitted to major tertiary care hospitals in Al Baha, Saudi Arabia, between April and August 2020.

Results: A total of 811 people were admitted for COVID-19 treatment, age ranging from 14 to 66, diabetes mellitus (31%, n = 248) and hypertension (24%, n = 198) were the most common comorbid conditions. The hydroxychloroquine (HCQ) treated group (G1 n = 466) had an MD of 8 and an IQR of 5-13 for time in hospital with a 4.3% mortality rate, while the non-HCQ group (G2 n = 345) had an MD of 6 and an IQR of 3-11 for time in hospital with a 3.2% mortality rate. A combination of antiviral and antibiotic treatment was found to be effective, other most frequent intervention was analgesics 85.7%, anticoagulant 75%, minerals (Zinc 83% and Vit D3 82%).

Conclusions: The therapy and clinical outcomes from the past will be the guiding factor to treat the COVID variants infection in the future. Patients treated with HCQ had a higher mortality rate, whereas those who were given a non-HCQ combination had a greater clinical outcome profile.

Data availability: Data available on request due to ethical restrictions. The anonymized data presented in this study are available on request from the corresponding author. The data are not publicly available to maintain privacy and adhere to guidelines of the ethics protocol.

Keywords: Antibiotics; COVID-19; Hydroxychloroquine; Mild infection; Saudi Arabia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Shows the (A) Percentage of the patients with the symptoms of COVID-19 and (B) Vital signs.
Fig. 2
Fig. 2
Shows percentage of clinical characteristics of patients.
Fig. 3
Fig. 3
Represents percentage of mortality and hospital stay time in patients treated with hydroxychloroquine and non-hydroxychloroquine.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. - PMC - PubMed
    1. Ebrahim S., Memish Z. Saudi Arabia’s measures to curb the covid-19 outbreak: temporary suspension of the Umrah pilgrimage. J Travel Med. 2020:20. - PMC - PubMed
    1. Chen Z., Tian Y., Liu L., An J. Production of a monoclonal antibody against non-structural protein 3 of dengue-2 virus by intrasplenic injection. Hybridoma. 2008;27:467–471. - PubMed
    1. Yang Y., Hu X., Xiong L., et al. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection. BMC Infect Dis. 2021;21:1–8. - PMC - PubMed
    1. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed

Substances

Supplementary concepts